2 Monster Stocks to Hold for the Next 10 Years LongTerm Growth Perspectives Microns New Milestone Dicks Earnings and Paxtons Victory Over Cornyn Lead CNBC Morning Squawk Microns Resurgence 133 Rally from Lows Raises Valuation Questions Trump Skips Son Donald Jrs Wedding Personal Matter Sparks Limited Market Chatter Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Operational Performance Eli Lilly Edges Higher on Nearly 4B Vaccine Deal Expansion PHGE Q4 2025 Earnings EPS Misses Estimates Significantly Stock Rises 105 Citi Trends Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Stock Surges UHT Q1 2026 Earnings EPS Beats in Absence of Consensus Shares Edge Higher Ingevity Corporation Q1 2026 Earnings EPS Surges 45 Above Consensus Stock Rises Instil Bio Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment HOMB Q1 2026 Earnings EPS Slightly Misses Estimate Shares Modestly Higher Oxford Lane Capital 2029 Preferred Shares OXLCO Hold Steady as FixedIncome Market Finds Footing Cadrenal Therapeutics CVKD Holds Steady Consolidating Between Support and Resistance BlackRock Virginia Municipal Bond Trust BHV Posts 119 Gain Approaching Key Resistance Intercontinental Exchange ICE Slips 122 as Resistance Holds Near 15866 W P Carey Inc WPC Shows Modest Gains as REIT Sector Navigates Interest Rate Uncertainty Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins SMMT Q1 2026 Earnings EPS Misses Estimates as Development Costs Mount Halozyme Stays Above Support After Minor Decline Key Levels to Watch